pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 1·1 min read
save

Residency dismissals disproportionately affect Black and Latino trainees despite medical school diversification

Jun 1, 2026·read at STAT ↗Negative

Medical schools have made notable progress in diversifying their student bodies, with enrollment of Black and Latino students rising over the past decade through pipeline programs, scholarships, and targeted recruitment.

Despite these gains, the overall physician workforce has not seen a comparable shift. The transition from medical school to independent practice hinges on completing a residency, a multi‑year apprenticeship that serves as the sole pathway to board certification.

Unpublished 2015 data from the Accreditation Council for Graduate Medical Education reveal that Black residents make up only about 5% of all trainees yet account for roughly 20% of residency dismissals, highlighting a stark disparity in how the pipeline narrows.

The author argues that the system, which funds residency training, must address these inequities rather than allowing disciplinary actions to disproportionately end the careers of historically excluded groups.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Medical schools diversified. So where are all the diverse doctors?”

read at STAT ↗
1,124 words · retrieved Jun 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
PATHRISING
topics
CardiologyDrug ShortageGLP-1 receptorHematology

related stories

  • 5d agoSignificant stock movers of September: Viking soars, Longeveron slidesBioSpace
  • Sep 22Novo targets 10-fold jump in oral Wegovy manufacturing capacity by 2030BioSpace
  • Sep 21Are healthcare systems really ready for GLP-1s?BioPharma Dive
  • Aug 12Opinion: Climate change is making people with chronic illness even sickerSTAT
  • Jul 23Lilly preps FDA run for ‘triple-G’ weight loss drug with Phase 3 dataBioSpace